Education
About Us
Working with TipRanks
Follow Us
Inoviq Ltd (AU:IIQ)
:IIQ
IIQ Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.35 - AU$0.69
Previous CloseN/A
Volume76.26K
Average Volume (3M)128.17K
Market Cap
AU$44.09M
Enterprise ValueAU$47.86M
Total Cash (Recent Filing)AU$9.23M
Total Debt (Recent Filing)AU$403.74K
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding111,632,805
10 Day Avg. Volume66,381
30 Day Avg. Volume128,167
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.50Price Target Upside25.00% Upside
Rating ConsensusHold
Number of Analyst Covering0
Inoviq Ltd News
IIQ FAQ
What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.34 and its highest was AU$0.69 in the past 12 months.
What is Inoviq Ltd’s market cap?
Inoviq Ltd’s market cap is AU$44.09M.
When is Inoviq Ltd’s upcoming earnings report date?
Inoviq Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 28 days.
How were Inoviq Ltd’s earnings last quarter?
Inoviq Ltd released its earnings results on Feb 20, 2025. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.033.
Is Inoviq Ltd overvalued?
According to Wall Street analysts Inoviq Ltd’s price is currently Undervalued.
Does Inoviq Ltd pay dividends?
Inoviq Ltd does not currently pay dividends.
What is Inoviq Ltd’s EPS estimate?
Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inoviq Ltd have?
Inoviq Ltd has 111,632,805 shares outstanding.
What happened to Inoviq Ltd’s price movement after its last earnings report?
Inoviq Ltd reported an EPS of -AU$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inoviq Ltd?
Currently, no hedge funds are holding shares in AU:IIQ
Inoviq Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.50 (25.00% Upside)
AU$0.50 (25.00% Upside)
Blogger Sentiment
Bullish
AU:IIQ Sentiment 70%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.50%
12-Months-Change
Fundamentals
Return on Equity
-39.07%
Trailing 12-Months
Asset Growth
15.05%
Trailing 12-Months
Company Description
Inoviq Ltd
Inoviq Ltd (IIQ) is a biotechnology company specializing in the development and commercialization of innovative diagnostic and therapeutic solutions aimed at improving patient outcomes. The company operates primarily in the healthcare sector, with a focus on cancer diagnostics and early detection technologies. Inoviq's core products include diagnostic tests and devices designed to enhance the precision and accuracy of cancer detection, providing significant value to healthcare providers and patients.
Technical Analysis
BCAL Diagnostics Limited
―
Rhythm Biosciences Ltd.
―
Lumos Diagnostics Holdings Ltd.
―
Genetic Signatures Ltd.
―
Ownership Overview
6.10% Insiders
―
Mutual Funds
― Other Institutional Investors
93.90% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---